Form 8-K - Current report:
SEC Accession No. 0001077183-22-000014
Filing Date
2022-02-23
Accepted
2022-02-23 07:14:57
Documents
14
Period of Report
2022-02-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neo-20220223.htm   iXBRL 8-K 38722
2 EX-99.1 a99112312021earningsrelease.htm EX-99.1 442339
6 image1.jpg GRAPHIC 1059753
  Complete submission text file 0001077183-22-000014.txt   2066705

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT neo-20220223.xsd EX-101.SCH 1908
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT neo-20220223_lab.xml EX-101.LAB 24993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT neo-20220223_pre.xml EX-101.PRE 13187
8 EXTRACTED XBRL INSTANCE DOCUMENT neo-20220223_htm.xml XML 11265
Mailing Address 9490 NEOGENOMICS WAY FORT MYERS FL 33912
Business Address 9490 NEOGENOMICS WAY FORT MYERS FL 33912 2397680600
NEOGENOMICS INC (Filer) CIK: 0001077183 (see all company filings)

EIN.: 742897368 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35756 | Film No.: 22660604
SIC: 8734 Services-Testing Laboratories